)

Catheter Precision (VTAK) investor relations material
Catheter Precision Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Revenue for Q2 2025 increased 128% year-over-year to $212K, with six-month revenue up 103% to $355K, driven by LockeT and VIVO sales; LockeT sales offset a decline in VIVO sales in the EU.
Net loss attributable to the company was $5.1M for Q2 2025 and $9.2M for the six months, compared to $4.2M and $6.9M in the prior year periods, reflecting higher operating and R&D expenses.
CE Mark for LockeT received, enabling European sales to begin in Q3 2025.
Two asset acquisitions completed: Perikard LLC (pericardial access technology) and Cardionomic's CPNS System (late-stage heart failure treatment), both expensed as in-process R&D.
Management notes substantial doubt about the company's ability to continue as a going concern within 12 months due to recurring losses and limited liquidity.
Financial highlights
Q2 2025 revenue: $212K (Q2 2024: $93K); six-month revenue: $355K (2024: $175K).
Q2 2025 net loss: $5.1M (Q2 2024: $4.2M); six-month net loss: $9.2M (2024: $6.9M).
Gross profit for Q2 2025: $198K; gross margin improved due to volume-based discounts on LockeT.
Cash and cash equivalents at June 30, 2025: $838K; accumulated deficit: $301.5M.
Total assets as of June 30, 2025, were $25.6M; shareholders' equity was $6.5M.
Outlook and guidance
Operating losses and negative cash flows expected to continue until sales and gross profit increase sufficiently to cover expenses.
Additional financing will be required before the end of the current quarter to fund operations and repay short-term notes due January 2026.
LockeT sales expected to start in Europe in Q3 2025 following CE Mark approval.
Management is evaluating further ATM offerings and other financing options; failure to secure funding may require operational reductions or suspension.
Management anticipates increased product awareness and demand in both US and international markets.
Next Catheter Precision earnings date

Next Catheter Precision earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage